EUVIMEDEUVIMED entdecken
Open Access

Activation of Evolutionarily Young Endogenous Retroviruses Is Implicated in COVID‐19 Immunopathology

Reia Yoshida, Hitoshi Ohtani iD

Genes to Cells · 2025

DOI: 10.1111/gtc.13194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Reia Yoshida und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: COVID-19, Endogenous Retroviruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysfunction of the innate immune system is well‐described as a clinical characteristic of COVID‐19. While several groups have reported human endogenous retroviruses (ERVs) as enhancing factors of immune reactivity, characterization of the COVID‐19‐specific ERVs has not yet been sufficiently conducted. Here, we revealed the transcriptome profile of more than 500 ERV subfamilies and innate immune response genes in eight different cohorts of platelet, peripheral blood mononuclear cells (PBMCs), lung, frontal cortex of brain, ventral midbrain, pooled human umbilical vein endothelial cells (pHUVECs), placenta, and cardiac microvascular endothelial cells (HCMEC) from COVID‐19 patients (total; n = 124) and normal samples (total; n = 53) using publicly available datasets. While upregulation of ERV subfamilies was found in platelets, PBMCs, and placenta, the immune reactivity was confined to only platelets and PBMCs. It is noteworthy that the evolutionary ages of the upregulated ERV subfamilies detected in platelets and PBMCs were younger than other ERV subfamilies, but the tendency was not seen in the upregulated ERV subfamilies in placenta. The results suggest that only evolutionarily young ERVs can function as enhancing factors of the immune reactivity in COVID‐19 patients. The finding should be instrumental in understanding the COVID‐19 immunopathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Endogenous RetrovirusesHumansFemaleSARS-CoV-2Immunity, InnatePregnancyTranscriptomePlacentaLeukocytes, MononuclearEvolution, MolecularHuman Umbilical Vein Endothelial CellsBlood Platelets

Stichwörter der Autor:innen

COVID‐19human endogenous retrovirusesinnate immunity

Autor:innen und Institutionen

  • Department of Animal Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Aichi, Japan.

ORCID-Profile: Hitoshi Ohtani

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yoshida, R., & Ohtani, H. (2025). Activation of Evolutionarily Young Endogenous Retroviruses Is Implicated in COVID‐19 Immunopathology. Genes to Cells. https://doi.org/10.1111/gtc.13194

Vancouver

Yoshida R, Ohtani H. Activation of Evolutionarily Young Endogenous Retroviruses Is Implicated in COVID‐19 Immunopathology. Genes to Cells. 2025. doi:10.1111/gtc.13194

BibTeX
@article{Yoshida2025,
  author = {Yoshida, Reia and Ohtani, Hitoshi},
  title = {Activation of Evolutionarily Young Endogenous Retroviruses Is Implicated in COVID‐19 Immunopathology},
  journal = {Genes to Cells},
  year = {2025},
  doi = {10.1111/gtc.13194}
}
Kostenlos starten →